At the 14th International Conference on Genomics in Shenzhen, MGI Tech and Agilent Technologies signed a strategic agreement to deepen cooperation in high-throughput sequencing. The partnership integrates MGI’s DNBSEQ™ sequencing platforms with Agilent’s SLIMS laboratory information management system, creating a more efficient and reliable overall sequencing workflow.
The collaboration combines MGI’s strengths in sequencing technology, including DNA single-chain circularization, patterned arrays, cPAS chemistry, and low-error paired-end sequencing, with Agilent SLIMS, which offers comprehensive electronic lab notebooks, sample and workflow management, order tracking, and data visualisation. This integration enables seamless coordination between hardware and software, improving lab efficiency and compliance across clinical, research, and analytical settings.
MGI and Agilent first collaborated in 2017 at MGI’s Australian lab, achieving full integration between DNBSEQ platforms and SLIMS for inventory management and online process tracking. Building on this foundation, the new agreement aims to extend these capabilities globally, supporting high-throughput clinical applications, streamlined laboratory workflows, and enhanced service for researchers and diagnostic laboratories.
Key benefits of the partnership:
- Seamless connection of sequencing platforms with lab management software
- Enhanced efficiency in sample and workflow management
- Reliable, low-error sequencing data integrated with electronic records
- Support for clinical, research, and analytical high-throughput applications
Executives from both companies emphasised confidence in the collaboration. Liu Jian, Executive Vice President of MGI, noted the potential to improve laboratory operations and services, while John Sadler, Agilent Vice President, highlighted the long-term value of the partnership. This integration addresses growing demands for robust laboratory data management in clinical and research genomics.
